Bora Pharmaceuticals Co., LTD. (TPE:6472)

United States Steel Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	85,543	77,712	64,612	31,121	12,446	10,634
Market Cap Growth	5.12%	20.27%	107.61%	150.04%	17.05%	89.60%
Enterprise Value	100,361	92,091	67,752	36,584	13,828	11,299
Last Close Price	827.00	738.79	618.15	305.78	121.60	103.49
PE Ratio	15.53	19.73	21.32	22.36	16.60	18.38
Forward PE	19.34	16.07	21.03	11.57	14.97	21.75
PS Ratio	4.10	4.04	4.55	2.97	2.54	5.91
PB Ratio	5.64	5.18	5.49	6.05	3.95	4.31
P/TBV Ratio	13.00	14.33	18.95	13.07	4.18	4.32
P/FCF Ratio	168.18	171.66	14.97	17.14	11.60	372.33
P/OCF Ratio	78.55	79.23	14.01	15.48	10.07	59.81
EV/Sales Ratio	4.81	4.79	4.77	3.49	2.82	6.28
EV/EBITDA Ratio	24.35	21.72	11.82	16.87	11.42	31.90
EV/EBIT Ratio	32.87	27.23	12.91	19.03	13.22	49.98
EV/FCF Ratio	197.31	203.42	15.70	20.15	12.89	395.62
Debt / Equity Ratio	1.18	1.26	0.42	1.48	0.70	1.17
Debt / EBITDA Ratio	4.23	4.36	0.86	3.44	1.80	7.88
Debt / FCF Ratio	35.28	41.91	1.16	4.18	2.07	100.89
Asset Turnover	0.54	0.54	0.59	0.70	0.68	0.35
Inventory Turnover	3.92	3.01	3.48	5.19	3.16	1.56
Quick Ratio	1.04	1.26	0.91	0.95	0.96	0.61
Current Ratio	1.42	1.71	1.29	1.17	1.52	1.15
Return on Equity (ROE)	45.45%	30.18%	36.34%	33.80%	26.69%	28.09%
Return on Assets (ROA)	5.12%	5.98%	13.70%	7.97%	9.10%	2.72%
Return on Capital (ROIC)	7.40%	8.33%	22.25%	13.27%	12.20%	3.36%
Return on Capital Employed (ROCE)	10.10%	10.60%	31.10%	15.70%	18.90%	4.80%
Earnings Yield	5.40%	5.07%	4.69%	4.47%	6.02%	5.44%
FCF Yield	0.59%	0.58%	6.68%	5.83%	8.62%	0.27%
Dividend Yield	1.70%	1.90%	1.94%	2.01%	2.01%	1.08%
Payout Ratio	26.67%	31.30%	20.43%	17.16%	14.64%	14.39%
Buyback Yield / Dilution	-9.20%	-8.17%	-4.93%	-1.41%	-0.86%	-7.55%
Total Shareholder Return	-7.49%	-6.28%	-2.99%	0.61%	1.16%	-6.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.